Alnylam Pharmaceuticals Inc (ALNY)
257.91
-6.69
(-2.53%)
USD |
NASDAQ |
Nov 14, 16:00
256.21
-1.70
(-0.66%)
After-Hours: 20:00
Alnylam Pharmaceuticals Cash and Short Term Investments (Quarterly): 2.780B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.780B |
| June 30, 2024 | 2.625B |
| March 31, 2024 | 2.371B |
| December 31, 2023 | 2.439B |
| September 30, 2023 | 2.406B |
| June 30, 2023 | 2.058B |
| March 31, 2023 | 2.071B |
| December 31, 2022 | 2.192B |
| September 30, 2022 | 2.265B |
| June 30, 2022 | 2.111B |
| March 31, 2022 | 2.240B |
| December 31, 2021 | 2.436B |
| September 30, 2021 | 2.328B |
| June 30, 2021 | 1.900B |
| March 31, 2021 | 1.710B |
| December 31, 2020 | 1.874B |
| September 30, 2020 | 1.834B |
| June 30, 2020 | 1.926B |
| March 31, 2020 | 1.342B |
| December 31, 2019 | 1.536B |
| September 30, 2019 | 1.721B |
| June 30, 2019 | 1.927B |
| March 31, 2019 | 1.245B |
| December 31, 2018 | 1.084B |
| September 30, 2018 | 1.237B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.448B |
| March 31, 2018 | 1.568B |
| December 31, 2017 | 1.691B |
| September 30, 2017 | 948.29M |
| June 30, 2017 | 923.27M |
| March 31, 2017 | 559.60M |
| December 31, 2016 | 626.80M |
| September 30, 2016 | 713.14M |
| June 30, 2016 | 856.40M |
| March 31, 2016 | 1.014B |
| December 31, 2015 | 1.081B |
| September 30, 2015 | 1.016B |
| June 30, 2015 | 1.005B |
| March 31, 2015 | 1.067B |
| December 31, 2014 | 696.69M |
| September 30, 2014 | 631.93M |
| June 30, 2014 | 654.76M |
| March 31, 2014 | 665.49M |
| December 31, 2013 | 245.87M |
| September 30, 2013 | 193.78M |
| June 30, 2013 | 209.69M |
| March 31, 2013 | 236.01M |
| December 31, 2012 | 122.81M |
| September 30, 2012 | 228.34M |
| June 30, 2012 | 229.02M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.342B
Minimum
Mar 2020
2.780B
Maximum
Sep 2024
2.122B
Average
2.152B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Pfizer Inc | 9.952B |
| BridgeBio Pharma Inc | 447.77M |
| Biomarin Pharmaceutical Inc | 930.44M |
| Gilead Sciences Inc | 5.037B |
| Regeneron Pharmaceuticals Inc | 9.796B |